Thursday, July 9, 2026

pharma · Netherton Syndrome · QNRX

Quoin Pharmaceuticals

Quoin Pharmaceuticals drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Ashburn, USA HQ
2018 Founded
9 Employees
Public company Type
QNRX · NYSE Ticker
Company details
Intelligence · Drug Pipeline

Quoin Pharmaceuticals pipeline

Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Quoin Pharmaceuticals drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

No drugs indexed yet

We have not linked approved or pipeline drugs to this company profile yet.

View clinical projects →